Chronic myelomonocytic leukemia (CMML) has dysplastic and proliferative features. The median age of patients with CMML is 70 years; the median survival is approximately 2 years. Various chemotherapy regimens have been used with only modest success. When the proliferative phase prevails, hydroxyurea is the treatment of choice. For younger patients with high-risk CMML, an allogeneic bone marrow transplantation should be considered. If a donor cannot be identified, then combination acute myeloid leukemia-type therapy followed by an autologous stem cell or marrow transplant should be offered. Clinical trials should be considered if available because the overall results of therapeutic interventions are far from optimal.
The association of chronic lymphatic leukemia (CLL) with Hodgkin’s disease (HD) is rare. A review of the literature revealed only 19 cases previously reported and 2 additional cases are herein described. CLL is generally the initial phase of this clinical combination and HD is typically diagnosed at postmortem. Tuberculosis was found concomitantly in 5 cases and suspected in 3 additional cases. The development of HD in patients with CLL is most probably coincidental.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.